Biomerica, Inc. - SIC # 3841 - SURGICAL AND MEDICAL INSTRUMENTS AND APPARATUS

Ticker Exchange SIC # Website Latest Ticker
BMRA Nasdaq 3841 http://www.biomerica.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Biomerica, Inc.

Biomerica Announces Third Quarter Financial Results - Apr 16th, 2019 7:18 am
Biomerica Announces Notice of Allowance for New U.S. Patent Application Covering Diagnostic Guided Therapy for Irritable Bowel Syndrome (IBS) - Apr 8th, 2019 6:19 am
LD Micro Virtual Conference Is Live, March 12th and 13th - Mar 12th, 2019 6:45 am
What You Must Know About Biomerica, Inc.’s (NASDAQ:BMRA) Beta Value - Feb 21st, 2019 12:49 pm
Biomerica Announces Updates for H. Pylori Clinical Studies - Feb 5th, 2019 6:19 am
An Intrinsic Calculation For Biomerica, Inc. (NASDAQ:BMRA) Shows It’s 32.14% Undervalued - Jan 22nd, 2019 12:42 pm
BMRA: Q2’19 Results: Asia Continues to Accelerate, Europe Rebounds, U.S. Still Weak But Could Return to Growth - Jan 21st, 2019 9:00 am
Biomerica Announces Second Quarter Financial Results - Jan 15th, 2019 6:19 am
Medline and Biomerica sign agreement for distribution of Biomerica’s colorectal screening test to help identify an early warning sign of colorectal cancer - Nov 28th, 2018 6:19 am
Consolidated Research: 2018 Summary Expectations for ProQR Therapeutics N.V, Biomerica, VEREIT, Apergy, Zendesk, and Arcus Biosciences — Fundamental Analysis, Key Performance Indications - Nov 16th, 2018 6:55 am
Can We See Significant Insider Ownership On The Biomerica Inc (NASDAQ:BMRA) Share Register? - Nov 16th, 2018 5:30 am
Biomerica’s Diagnostic Product Guides Exclusionary Diet Treatment to Successfully Alleviate Symptoms of Ulcerative Colitis (UC) in Prospective Clinical Stud - Nov 7th, 2018 7:42 am
BMRA: Q1 2019: Asia Strong, Europe & U.S. Weak. Revenue up 13% QoQ But Down 12% yoy. Expense Control Minimizes Op Loss. - Oct 22nd, 2018 11:15 am
Is Biomerica Inc (NASDAQ:BMRA) A Financially Sound Company? - Sep 26th, 2018 10:00 am
BMRA: Legacy Biz Slows in Q4. Operational Highlights Include InFoods Enrolling, Ex-Walgreens CMO Joins SAB (and we’re intrigued) - Sep 7th, 2018 8:00 am
When Can We Expect A Profit From Biomerica Inc (NASDAQ:BMRA)? - May 31st, 2018 6:26 pm